Boston Private Bank & Trust’s Gilead Sciences GILD Stock Holding History

Boston Private Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$24.2M	Buy	246,875 +8,923	+4%	+$906K	1.12%	24
2014 Q4	$22.4M	Sell	237,952 -2,601	-1%	-$269K	1.04%	24
2014 Q3	$25.6M	Sell	240,553 -2,145	-0.9%	-$210K	1.25%	16
2014 Q2	$20.1M	Buy	242,698 +3,177	+1%	+$247K	0.98%	26
2014 Q1	$17M	Sell	239,521 -3,310	-1%	-$260K	0.86%	32
2013 Q4	$18.2M	Sell	242,831 -7,510	-3%	-$523K	0.91%	32
2013 Q3	$15.7M	Sell	250,341 -35,250	-12%	-$2.11M	0.87%	30
2013 Q2	$14.6M	Buy	+285,591	New	+$14.9M	0.85%	32

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Boston Private Bank & Trust's GILD Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Gilead Sciences (GILD) stake by 3.7% in Q1 2015, buying an estimated $906K and bringing the position to 246,875 shares worth $24.2M. The position accounts for 1.12% of the portfolio, ranked #24.

Boston Private Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 8 quarters since. The position peaked at $25.6M in Q3 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

Boston Private Bank & Trust held 246,875 shares of Gilead Sciences worth $24.2M as of Q1 2015.
Boston Private Bank & Trust bought 8,923 Gilead Sciences shares in Q1 2015, an estimated $906K.
Gilead Sciences made up 1.12% of Boston Private Bank & Trust's portfolio in Q1 2015, its #24 holding.
Boston Private Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Gilead Sciences position peaked at $25.6M in Q3 2014.
1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.